Christopher W. Krueger
2021
In 2021, Christopher W. Krueger earned a total compensation of $2.5M as Chief Business Officer at Ventyx Biosciences, a 4,533% increase compared to previous year.
Compensation breakdown
| Bonus | $195,500 |
|---|---|
| Option Awards | $1,340,319 |
| Salary | $372,645 |
| Stock Awards | $606,958 |
| Total | $2,515,422 |
Krueger received $1.3M in option awards, accounting for 53% of the total pay in 2021.
Krueger also received $195.5K in bonus, $372.6K in salary and $607K in stock awards.
Rankings
In 2021, Christopher W. Krueger's compensation ranked 5,125th out of 12,415 executives tracked by ExecPay. In other words, Krueger earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,125 out of 12,415 | 59th |
Division Manufacturing | 2,154 out of 5,501 | 61st |
Major group Chemicals And Allied Products | 926 out of 2,371 | 61st |
Industry group Drugs | 827 out of 2,092 | 61st |
Industry Pharmaceutical Preparations | 591 out of 1,542 | 62nd |
Source: SEC filing on April 27, 2022.
Krueger's colleagues
We found two more compensation records of executives who worked with Christopher W. Krueger at Ventyx Biosciences in 2021.